Antibody Scaffold Deep Pocket HCDR3 RNA-Protein Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current technologies lack the ability to effectively identify and generate antibodies with new binding specificities for RNA-protein complexes, limiting their application in therapeutic and diagnostic fields, particularly in cancer treatment.

Innovation Solution

Development of an antibody scaffold with a deep pocket and specific HCDR3 structure, allowing for the generation of antibodies with altered binding specificities through mutation and screening, targeting RNA-protein complexes such as polyadenylate-binding protein 1 (PABP-1) for therapeutic and diagnostic applications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional antibody technologies are used, then existing binding specificities are maintained, but the ability to identify antibodies with new binding specificities for RNA-protein complexes is limited

Engineering Contradiction:
Improvebinding specificityVSAvoididentification efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent applies preliminary action by pre-designing an antibody scaffold structure with a deep pocket and specific HCDR3 configuration before the actual antibody identification process. This pre-engineered scaffold is then used as a template for generating antibodies with novel binding specificities, improving both adaptability and identification efficiency for RNA-protein complexes

Inventive Principle:
Principle #10Preliminary action

2Adaptability or versatility

If antibody scaffold with deep pocket and specific HCDR3 structure is used, then antibodies with new binding specificities can be generated, but the structural complexity increases

Engineering Contradiction:
Improvebinding specificityVSAvoidscaffold structure
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent applies local quality by introducing specific structural features (deep pocket and disulfide bonds) only in the critical HCDR3 region of the antibody scaffold, rather than complicating the entire antibody structure. This localized structural modification enables novel binding specificities while minimizing overall structural complexity

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs composite materials by combining the antibody scaffold with RNA-protein complex targets, creating a composite system where the scaffold's deep pocket structure selectively binds to specific epitopes on the RNA-protein complexes, enabling generation of antibodies with new binding specificities

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS20230381130A1Antibody scaffold structure
Publication Date: 2023.11.30 ATRECA INC
  • US20230381130A1 patent drawing
  • US20230381130A1 patent drawing
  • US20230381130A1 patent drawing

AI summary

Provided herein are antibodies comprising a scaffold region and methods of using such antibodies to generate antibodies with binding specificities that differ from a parent antibody that comprises the scaffold region.